Clinical Trial Update: Feasibility and Clinically Application of Magnetic Resonance Fingerprinting [NA]

View source ↗

Summary

Clinical trial investigating magnetic resonance fingerprinting in Neurofibromatosis type 1 with brain tumors was terminated; results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor
• Glioma
• Neurofibromatosis Type

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Neurofibromatosis Type 1, Brain Tumor | NA | Status: TERMINATED | Results posted: 2021-01-12